The Knowledge and Views of Indian Researchers

Authors

  • Vishal Vennu School of Pharmacy, Lingaya’s Vidyapeeth, Faridabad, India and Department of Rehabilitation Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.

DOI:

https://doi.org/10.9734/bpi/mono/978-93-91882-02-0/CH8

Keywords:

Researcher, clinical trial, regulations, governmental rules, drug, ethical, India

Abstract

No study studied the knowledge and views of Indian researchers about changes in the new drugs and clinical trial rules (NDCTR-19). The present study aimed to address this gap. In this cross-sectional web-based online survey, a total of 106 male and female researchers were chosen randomly from various sources across India over three months, starting from July 2019. The study results suggest that most researchers know and agree with the modifications. NDCTR-19 forces to extend clinical research and the pharmaceutical industry in India. Overall, this study strengthens the aim of the NDCTR-19 that promotes clinical trials, accepts new drugs, and enhances the country's standards ethical norms.

Published

2021-08-30

How to Cite

Vishal Vennu. (2021). The Knowledge and Views of Indian Researchers. India’s New Drugs and Clinical Trial Rules: Perception and Perspectives of Indian Researchers, 38–46. https://doi.org/10.9734/bpi/mono/978-93-91882-02-0/CH8

Issue

India’s New Drugs and Clinical Trial Rules: Perception and Perspectives of Indian Researchers

Section

Contents